Last reviewed · How we verify

NCT05486637

Vocal Emotion Communication With Cochlear Implants

Recruiting now EARLY_PHASE1 Last updated 19 September 2025
What this trial tests

EARLY_PHASE1 trial testing Perception of acoustic cues to emotion in Cochlear Hearing Loss in 255 participants. Currently enrolling.

Timeline
1 July 2022
Primary endpoint
30 June 2027
30 June 2027

Quick facts

Lead sponsorFather Flanagan's Boys' Home
PhaseEARLY_PHASE1
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposebasic science
Enrollment255
Start date1 July 2022
Primary completion30 June 2027
Estimated completion30 June 2027
Sites4 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Father Flanagan's Boys' Home

Who can join

Adults 6 to 80, any sex, with Cochlear Hearing Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients with hearing loss who use cochlear implants (CIs) show significant deficits and strong unexplained intersubject variability in their perception and production of spoken emotions in speech. This project will investigate the hypothesis that "cue-weighting", or how patients utilize the different acoustic cues to emotion, accounts for significant variance in emotional communication with CIs. The results will focus on children with CIs, but parallel measures in postlingually deaf adults with CIs will be made, ensuring that results of these studies benefit social communication by CI patients across the lifespan by informing the development of technological innovations and improved clinical protocols.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cochlear Hearing Loss

Currently open trials in the same condition.

Other Father Flanagan's Boys' Home trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05486637.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing